Regulatory & Policy
EDE makes UAE 3rd global market for Jascayd pulmonary fibrosis drug
EDE approved Jascayd for adult IPF and PPF patients on 19 June 2026, putting UAE providers on the clock for formulary, pathway and payer decisions.
20 Jun 2026 · 3 min read

